FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ruth Frikke-Schmidt

Research Profile

Disorders

Myocardial Ischemia

Physiology

Geographic Areas

Denmark

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Louise S Hornstrup; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Anette Varbo; Anne Tybjaerg-Hansen; Marianne Benn; Ruth Frikke-Schmidt; Anders B Jørgensen; Børge G Nordestgaard
Remnant cholesterol as a causal risk factor for ischemic heart disease.
Stefan Stender; Marianne Benn; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ruth Frikke-Schmidt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Louise S Hornstrup; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(6):1441-7.
2013: Anette Varbo; Anne Tybjaerg-Hansen; Marianne Benn; Ruth Frikke-Schmidt; Anders B Jørgensen; Børge G Nordestgaard
Remnant cholesterol as a causal risk factor for ischemic heart disease.
Journal of the American College of Cardiology 2013;61(4):427-36.
2013: Stefan Stender; Marianne Benn; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.
Journal of hepatology 2013;58(1):126-33.
2013: S Stender; Ruth Frikke-Schmidt; P Grande; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Journal of internal medicine 2013;273(1):59-68.
2012: Jesper Schou; Anne Tybjaerg-Hansen; Holger J Møller; Børge G Nordestgaard; Ruth Frikke-Schmidt
ABC transporter genes and risk of type 2 diabetes: a study of 40,000 individuals from the general population.
Diabetes care 2012;35(12):2600-6.
2012: Trine Holm Johannsen; Børge G Nordestgaard; Jesper Schou; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Journal of the American College of Cardiology 2012;60(20):2041-8.
2012: Christina Christoffersen; Björn Dahlbäck; Ruth Frikke-Schmidt; Philip L S M Gordts; Marianne Benn; Pernille M Christensen; Anton J M Roebroek; Anne Tybjaerg-Hansen; Lars B Nielsen
The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
Journal of lipid research 2012;53(10):2198-204.
2012: Jesper Schou; Efstathia Thymiakou; Ruth Frikke-Schmidt; Peer Grande; Gorm Jensen; Dimitris Kardassis; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(2):506-15.
2012: Christiane L Haase; Børge G Nordestgaard; Jesper Schou; Anne Tybjaerg-Hansen; Abbas Ali Qayyum; Ruth Frikke-Schmidt
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
The Journal of clinical endocrinology and metabolism 2012;97(2):E248-56.
2012: Christiane L Haase; Børge G Nordestgaard; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen
Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach.
PLoS genetics 2012;8(11):e1003063.
2011: Stefan Stender; Aristomenis Anestis; Ruth Frikke-Schmidt; Dimitris Kardassis; Børge G Nordestgaard; Amar A Sethi; Anne Tybjaerg-Hansen
Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(12):2990-6.
2011: Louise S Hornstrup; Børge G Nordestgaard; Henrik Sillesen; Anne Tybjaerg-Hansen; Peer Grande; Christiane L Haase; Ruth Frikke-Schmidt
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Circulation. Cardiovascular genetics 2011;4(5):534-41.
2011: Ruth Frikke-Schmidt
Genetic variation in ABCA1 and risk of cardiovascular disease.
Atherosclerosis 2011;218(2):281-2.
2011: Marianne S Nørskov; Henrik Sillesen; Ruth Frikke-Schmidt; Peer Grande; Steffen Loft; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses.
Circulation. Cardiovascular genetics 2011;4(4):418-28.
2011: C L Haase; A H Johnsen; D Kardassis; A K Kateifides; Lars Køber; L B Nielsen; Børge G Nordestgaard; C B Andersen; Ruth Frikke-Schmidt; P Grande; V I Zannis; Anne Tybjaerg-Hansen
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.
Journal of internal medicine 2011;270(2):136-46.
2011: M S Nørskov; Stig E Bojesen; Ruth Frikke-Schmidt; S Loft; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population.
The pharmacogenomics journal 2011;11(4):292-9.
2011: Marianne Benn; Anne Tybjaerg-Hansen; Stefan Stender; Ruth Frikke-Schmidt; Børge G Nordestgaard
Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.
Journal of the National Cancer Institute 2011;103(6):508-19.
2011: Stefan Stender; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population.
Hepatology (Baltimore, Md.) 2011;53(2):640-8.
2011: Ratna Karuna; Adriaan G Holleboom; Mohammad M Motazacker; Jan Albert Kuivenhoven; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Spiros Georgopoulos; Miranda van Eck; Theo Van berkel; Arnold von Eckardstein; Katharina M Rentsch
Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
Atherosclerosis 2011;214(2):448-55.
2011: Holger Jon Møller; Ruth Frikke-Schmidt; Søren K Moestrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Clinical chemistry 2011;57(2):291-7.
2011: Mette Christoffersen; Ruth Frikke-Schmidt; Gorm B Jensen; Børge G Nordestgaard; Peter Schnohr; Anne Tybjaerg-Hansen
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.
BMJ (Clinical research ed.) 2011;343():d5497.
2010: Christiane L Haase; Anne Tybjaerg-Hansen; Peer Grande; Ruth Frikke-Schmidt
Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
The Journal of clinical endocrinology and metabolism 2010;95(12):E500-10.
2010: Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard
Common clinical practice versus new PRIM score in predicting coronary heart disease risk.
Atherosclerosis 2010;213(2):532-8.
2010: Jari H Stengård; Greg Dyson; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Borge G Nordestgaard; Charles F Sing
Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women.
Circulation. Cardiovascular genetics 2010;3(1):22-30.
2010: Ruth Frikke-Schmidt
Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.
Atherosclerosis 2010;208(2):305-16.
2009: Gregory E Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease.
Genetic epidemiology 2009;33(4):317-24.
2009: Julia S Johansen; Stig E Bojesen; Anne K Mylin; Ruth Frikke-Schmidt; Paul A Price; Børge G Nordestgaard
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):572-8.
2009: Marianne S Nørskov; Ruth Frikke-Schmidt; Steffen Loft; Anne Tybjaerg-Hansen
High-throughput genotyping of copy number variation in glutathione S-transferases M1 and T1 using real-time PCR in 20,687 individuals.
Clinical biochemistry 2009;42(3):201-9.
2009: Rasmus Sejersten Ripa; Erik Jørgensen; Federica Baldazzi; Ruth Frikke-Schmidt; Yongzhong Wang; Anne Tybjaerg-Hansen; Jens Kastrup
The influence of genotype on vascular endothelial growth factor and regulation of myocardial collateral blood flow in patients with acute and chronic coronary heart disease.
Scandinavian journal of clinical and laboratory investigation 2009;69(6):722-8.
2008: Iris M Heid; Eva Boes; Martina Müller; Barbara Kollerits; Claudia Lamina; Stefan Coassin; Christian Gieger; Angela Döring; Norman Klopp; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Anita Brandstätter; Andreas Luchner; Thomas Meitinger; H-Erich Wichmann; Florian Kronenberg
Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.
Circulation. Cardiovascular genetics 2008;1(1):10-20.
2008: Josefin Ahnström; Olof Axler; Matti Jauhiainen; Veikko Salomaa; Aki S Havulinna; Christian Ehnholm; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Björn Dahlbäck
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.
Journal of lipid research 2008;49(9):1912-7.
2008: Maria C A Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Peer Grande; Peter Schnohr; Anne Tybjaerg-Hansen
Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.
Journal of the American College of Cardiology 2008;52(5):369-77.
2008: Ruth Frikke-Schmidt; Børge G Nordestgaard; Maria C A Stene; Amar A Sethi; Alan T Remaley; Peter Schnohr; Peer Grande; Anne Tybjaerg-Hansen
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
JAMA : the journal of the American Medical Association 2008;299(21):2524-32.
2008: Ruth Frikke-Schmidt; Børge G Nordestgaard; Gorm B Jensen; Rolf Steffensen; Anne Tybjaerg-Hansen
Genetic variation in ABCA1 predicts ischemic heart disease in the general population.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(1):180-6.
2007: Jari H Stengård; Ruth Frikke-Schmidt; A Tybjaerg-Hansen; B G Nordestgaard; Charles F Sing
Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study.
Annals of human genetics 2007;71(Pt 6):762-71.
2007: Gregory E Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.
Genetic epidemiology 2007;31(6):515-27.
2007: Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Rolf Steffensen; Anne Tybjaerg-Hansen
Subsets of SNPs define rare genotype classes that predict ischemic heart disease.
Human genetics 2007;120(6):865-77.
2006: Maria C A Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Rolf Steffensen; Peter Schnohr; Anne Tybjaerg-Hansen
Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.
Atherosclerosis 2006;188(1):43-50.
2006: Tania L Slatter; Michael J A Williams; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Ian M Morison; Sally P A McCormick
Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
Atherosclerosis 2006;187(2):393-400.
2006: Maria C Stene; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population.
Journal of lipid research 2006;47(5):944-52.
2006: Jari H Stengård; Sharon L R Kardia; Sara C Hamon; Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Veikko Salomaa; Eric Boerwinkle; Charles F Sing
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia.
Journal of lipid research 2006;47(2):318-28.
2005: Ruth Frikke-Schmidt; Børge G Nordestgaard; Peter Schnohr; Rolf Steffensen; Anne Tybjaerg-Hansen
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population.
Journal of the American College of Cardiology 2005;46(8):1516-20.
2004: Ruth Frikke-Schmidt; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.
The Journal of clinical investigation 2004;114(9):1343-53.
2004: Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.
Human genetics 2004;115(4):331-45.
2004: Ruth Frikke-Schmidt; Børge G Nordestgaard; Peter Schnohr; Anne Tybjaerg-Hansen
Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study.
European heart journal 2004;25(11):943-51.
2001: Ruth Frikke-Schmidt; Børge G Nordestgaard; D Thudium; M L Moes Grønholdt; Anne Tybjaerg-Hansen
APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease.
Neurology 2001;56(2):194-200.
2000: Ruth Frikke-Schmidt; Hans H Wittrup; Anne Tybjaerg-Hansen; Hans Meinertz; Peter Schnohr; Børge G Nordestgaard
Apolipoprotein E genotypes predict attendance rates at lipid clinic.
Atherosclerosis 2000;153(2):461-8.
2000: Ruth Frikke-Schmidt; Børge G Nordestgaard; B Agerholm-Larsen; Peter Schnohr; Anne Tybjaerg-Hansen
Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
Journal of lipid research 2000;41(11):1812-22.
2000: Ruth Frikke-Schmidt; Anne Tybjaerg-Hansen; Rolf Steffensen; Gorm Jensen; Børge G Nordestgaard
Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study.
Journal of the American College of Cardiology 2000;35(5):1192-9.
2000: Ruth Frikke-Schmidt
Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2000;233():3-25.
1997: B Agerholm-Larsen; Anne Tybjaerg-Hansen; Ruth Frikke-Schmidt; Marie-Louise Moes Grønholdt; G Jensen; Børge G Nordestgaard
ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease.
Annals of internal medicine 1997;127(5):346-55.